SCHEMBL1629208

SCHEMBL1629208

COc1cc(OC)c(-c2ccnn2-c2ccccc2Cl)cc1Nc1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 4/20 0.43
FLT3 P36888 1/20 0.41
MAPK14 Q16539 2/20 0.40
MAPK11 Q15759 1/20 0.40
HSP90AA1 P07900 1/20 0.39
NR3C2 P08235 2/20 0.39
KCNN4 O15554 1/20 0.38
JAK2 O60674 1/20 0.37
PIM1 P11309 1/20 0.37
CDK2 P24941 1/20 0.37
MAPKAPK2 P49137 1/20 0.37
GSK3A P49840 1/20 0.37
CSNK2A1 P68400 1/20 0.37
PAK1 Q13153 1/20 0.37
STK3 Q13188 1/20 0.37
DYRK1A Q13627 1/20 0.37
MAPKAPK3 Q16644 1/20 0.37
PRKD2 Q9BZL6 1/20 0.37
PLK3 Q9H4B4 1/20 0.37
WEE1 P30291 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1629896 0.83 KCNN4 (0.44) FLT3MAPK14MAPK11HSP90AA1NR3C2
SCHEMBL1628861 0.81 HSP90AA1 (0.55) P2RX7MAPK14MAPK11HSP90AA1NR3C2
SCHEMBL1629564 0.81 HSP90AA1 (0.44) P2RX7FLT3MAPK14MAPK11HSP90AA1
SCHEMBL1630439 0.81 ALPL (0.47) MAPTMEN1KMT2A
SCHEMBL1630477 0.80 HSP90AA1 (0.51) HSP90AA1MAPTMEN1KMT2A
SCHEMBL1629172 0.79 HSP90AA1 (0.41) P2RX7HSP90AA1MAPTMEN1KMT2A
SCHEMBL1631632 0.78 HSP90AA1 (0.39) FLT3MAPK14MAPK11HSP90AA1NR3C2
SCHEMBL12722876 0.78 HSP90AA1 (0.46) P2RX7MAPK14HSP90AA1NR3C2KCNN4
SCHEMBL1630297 0.78 HSP90AA1 (0.41) FLT3MAPK14MAPK11HSP90AA1NR3C2
SCHEMBL1628547 0.77 CYP1A1 (0.41) MAPK14HSP90AA1NR3C2KCNN4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1776346-B1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2013-06-26 EP disclosed
US-7932401-B2 Heat Shock Protein 90 (HSP90) inhibitors; 5-(2-hydroxy-4-methoxyphenyl)-1-(3-nitrophenyl)-1H-pyrazole for example; antitumor agent, viral diseases, transplant rejection, cystic fibrosis, angiogenesis inhibition, infectious, autoimmune, or inflammatory diseases, ischemia, chemotherapy cytoprotectant MERCK PATENT GMBH (DE) 2011-04-26 US disclosed
US-20080085904-A1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2008-04-10 US disclosed
CN-101006061-A 1,5-diphenylpyrazoles MERCK PATENT GMBH (DE) 2007-07-25 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080085904-A1 1,5-Diphenylpyrazoles HSP90AB1, HSP90AA1, HSP90AB2P P2RX7 2214/4885FLT3 2266/4885MAPK14 1929/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.